tiprankstipranks
Poseida Therapeutics (PSTX)
NASDAQ:PSTX
Holding PSTX?
Track your performance easily

Poseida Therapeutics (PSTX) Financial Statements

478 Followers

Poseida Therapeutics Financial Overview

Poseida Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.633; its P/E ratio is -4.36; Poseida Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 71.75M$ 25.97M$ 28.14M$ 25.00M$ 9.35M
Gross Profit$ 71.75M$ 25.97M$ 28.14M$ 25.00M$ 9.35M
EBIT$ 22.57M$ -29.11M$ -22.02M$ -23.08M$ -29.43M
EBITDA$ 23.87M$ -26.18M$ -20.64M$ -21.64M$ -27.99M
Net Income Common Stockholders$ 20.23M$ -31.37M$ -24.27M$ -25.35M$ -31.78M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 230.85M$ 237.81M$ 198.65M$ 212.20M$ 238.84M
Total Assets$ 293.58M$ 298.69M$ 262.58M$ 273.88M$ 302.25M
Total Debt$ 82.73M$ 83.65M$ 84.56M$ 85.42M$ 86.26M
Net Debt$ -148.13M$ -154.16M$ -114.08M$ -126.78M$ -152.58M
Total Liabilities$ 206.37M$ 237.87M$ 177.99M$ 170.18M$ 178.59M
Stockholders Equity$ 87.21M$ 60.85M$ 84.56M$ 103.70M$ 123.66M
Cash Flow-
Free Cash Flow$ -10.24M$ 37.38M$ -15.23M$ -29.05M$ 7.10M
Operating Cash Flow$ -9.60M$ 38.40M$ -15.10M$ -28.74M$ 7.89M
Investing Cash Flow$ 27.65M$ -61.20M$ 24.00M$ 47.71M$ -47.24M
Financing Cash Flow$ 742.00K-$ -43.00K-$ 14.94M
Currency in USD

Poseida Therapeutics Earnings and Revenue History

Poseida Therapeutics Debt to Assets

Poseida Therapeutics Cash Flow

Poseida Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis